Model
Edge
Revance Therapeutics Inc.
0001803375
Filing Type
4
Filing Date
3/3/2024
Updated
3/4/24, 10:33 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership